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Abstract
Feasibility of chromosomal manipulation in mammalian cells was first reported 15 years ago. Although this technique is
useful for precise understanding of gene regulation in the chromosomal context, a limited number of laboratories have
used it in actual practice because of associated technical difficulties. To overcome the practical hurdles, we developed a Cre-
mediated chromosomal recombination system using fluorescent proteins and various site-specific recombinases. These
techniques enabled quick construction of targeting vectors, easy identification of chromosome-rearranged cells, and
rearrangement leaving minimum artificial elements at junctions. Applying this system to a human cell line, we successfully
recapitulated two types of pathogenic chromosomal translocations in human diseases: MYC/IgH and BCR/ABL1. By inducing
recombination between two loxP sites targeted into the same chromosome, we could mark cells harboring deletion or
duplication of the inter-loxP segments with different colors of fluorescence. In addition, we demonstrated that the
intrachromosomal recombination frequency is inversely proportional to the distance between two recombination sites,
implicating a future application of this frequency as a proximity sensor. Our method of chromosomal manipulation can be
employed for particular cell types in which gene targeting is possible (e.g. embryonic stem cells). Experimental use of this
system would open up new horizons in genome biology, including the establishment of cellular and animal models of
diseases caused by translocations and copy-number variations.
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Introduction
ModerngeneticengineeringdependsonDNA-modifyingenzymes
including restriction endonucleases, ligases and polymerases. This
technology has been applied to manipulation of purified DNA less
thanafewhundredkilobases.Broadeningtherangeofmanipulatable
DNA to megabase scale would be fundamental to deepen the
understanding of gene regulation in the chromosomal context. To
this purpose, chromosomal manipulation in mammalian cells by Cre
recombinase (a site-specific recombinase derived from bacteriophage
P1, catalyzing DNA recombination between two 34-bp loxP
sequences) after targeted integration of two loxP sites into defined
chromosomal loci has been reported previously [1–8]. These studies
relied exclusively on the selection of cells expressing hypoxanthine
phosphoribosyltransferase (HPRT) as an indicator of recombination,
and therefore, the use of HPRT-deficient cells was a prerequisite. In
this study, we introduced two improvements to this technology. First,
weutilizedfluorescentproteinsasrearrangementmarkerstobroaden
the range of cells this technology can be applied to. Second, to
facilitatetheotherwisecumbersomeconstructionoftargetingvectors,
weadoptedGatewaycloningsystem,whichutilizesinvitrosite-specific
recombination by l-phage-derived integrase complexes (BP and LR
Clonases) [9]. Here,we demonstrate threekinds of application of our
novel chromosomal manipulation: recapitulation of pathogenic
chromosomal translocation, induction of copy-number variation,
and assessment of proximity between gene loci.
Results and Discussion
New vectors for chromosomal manipulation
To monitor the integrity and fate of two junctions, we generated
loxP site-containing targeting vectors to encode green and red
fluorescent proteins after recombination. As shown in Fig. 1,
coding sequences of enhanced green fluorescent protein (GFP) and
the red fluorescent protein variant dimer2 [10] (DsRed) were split
in the middle and fused to each other with intervening drug
selection markers (hygromycin- or neomycin-resistance gene)
franked by loxP sites. Similar strategy utilizing restoration of
split-fluorescent protein by Cre recombinase was previously
adopted for analysis of neuronal differentiation in mice [11].
Our gene cassettes for split-fluorescent protein are bound by FRT
and att (L1 or L2) sites for later recognition by Flp recombinase (a
site-specific recombinase derived from the 2 mm plasmid of
budding yeast) and Gateway LR Clonase, respectively. These
constructed vectors can be easily converted to the final gene-
targeting vectors in a reaction with two homology-arm vectors and
a destination vector (i.e. pDEST DTA-MLS [12]), catalyzed by
LR Clonase.
In this study, we used Nalm-6, a human pre-B acute
lymphoblastic leukemia cell line with high gene-targeting efficien-
cy [13]. Before gene targeting, we stably transfected a vector
expressing 4-hydroxytamoxifen (OHT)-regulated Cre recombi-
nase (MerCreMer [14]) to Nalm-6 to obtain NCR1 cells.
PLoS ONE | www.plosone.org 1 March 2010 | Volume 5 | Issue 3 | e9846MerCreMer is a modified Cre both amino- and carboxyl-
terminally fused with hormone-binding domain of human estrogen
receptor a with mutations that reduces response to native
estrogens but not its synthetic analogue OHT (Mer stands for
mutated estrogen receptor). MerCreMer lacks Cre activity in the
absence of OHT but is activated promptly by OHT.
After linearization at multiple linearization sites (MLS), a Site1-
targeting vector was electroporated into NCR1 cells, followed by
PCR screening and Southern blotting. A targeted clone was
further subjected to a second targeting with a Site2 vector. Thus,
double-targeted clones were obtained. Addition of OHT at a later
stage can induce excision of drug-resistant markers, leaving a loxP
site at the GFP–DsRed junction. Then, continued Cre activity
would lead to recombination between the loxP sites in Site1 and
Site2. To remove GFP and DsRed expression units and loxP sites,
Flp recombinase was transiently expressed in GFP- and DsRed-
positive cells, leaving only the 103-bp artificial sequence of attB1-
FRT-attB2 (Fig. 1). We introduced this Flp recombinase-mediated
excision of fluorescent protein expression elements because
presence of those promoters may perturb expression of nearby
Figure 1. Scheme for vector construction and chromosomal recombination. (upper) pENTR-Site1 plasmid contains cytomegalovirus (CMV)
promoter-driven fusion gene, the first half consisting of GFP (green box) and the last half of dimer2 (a DsRed variant, red box) with an intervening
hygromycin-resistance gene (grey box) flanked by loxP sites (red triangles), outer two FRT sites (blue triangles) and attL1 and attL2 sites (open box).
pENTR-Site2 expresses a fusion gene complementary to pENTR-Site1 harboring a neomycin-resistance gene (grey box). These vectors in addition to
59- and 39-targeting homology arm vectors and the pDEST DTA-MLS destination vector were assembled into targeting vectors by LR Clonase. Purple
shadows connect att sites to be recombined. (lower) After gene targeting into homologous chromosomal regions, Cre first removes drug-resistance
genes and then recombines distant loxP sites. After recombination, GFP and dimer2 mRNAs are spliced and expressed. Expression of Flp excises
fluorescent protein genes to achieve clean rearrangement, leaving a 103-bp element. DTA, diphtheria toxin A; MLS, multiple linearization sites (PmeI,
AscI, I-SceI, SwaI, PacI); ori, replication origin; Km
R, kanamycin-resistance gene; Amp
R, ampicillin-resistance gene; ccdB, bacterial ccdB gene.
doi:10.1371/journal.pone.0009846.g001
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mediated excision of restored fluorescent protein genes as clean
(e.g. clean translocation).
Induction of chromosomal translocation
To test the feasibility of this system, we recapitulated two
pathogenic chromosomal translocations in human hematological
malignancies: t(8;14)(q24;q32) (MYC/IgH) found in Burkitt lym-
phoma and t(9;22)(q34;q11.2) (BCR/ABL1) in chronic myeloid
leukemia. As shown in Fig. 2A, we introduced Site1 within the
immunoglobulin heavy chain a2( IGHA2) locus on the telomeric
side of the IgH 39 enhancer in MerCreMer-expressing NCR1 cells
(Fig. S1). One of the six clones with correct targeting was
designated NSB1. Subsequently, the MYC locus of NSB1 cells was
targeted by Site2 vector and four targeted clones were obtained
(NSMyc, Fig. S2), of which three clones were cultured in the
presence or absence of OHT for 7 days and analyzed by flow
cytometry.
The frequency of GFP-DsRed double-positive cells was
(1.561.2)610
25 [mean 6 standard deviation, n=3]. Enforcement
of Cre activity by a retroviral vector increased the frequency of
double-positive cells by more than 40 fold (6.8610
24), indicating
that Cre activity is a major factor influencing translocation
efficiency. We continued Cre activation of one clone, NSMyc23,
until day 20, when we sorted the double-positive cells (Fig. 2B).
The sorted cells were then subjected to limiting dilution to obtain
pure clones of double-positive cells, followed by electroporation of
a Flp-expression plasmid to achieve a clean translocation. The
resulting double-negative cells were cloned by sorting and limiting
dilution. Chromosomal translocation was verified by polymerase
chain reaction (PCR) using MYC/IgH translocation-specific
primers (Fig. 2C) and by fluorescence in situ hybridization (FISH)
using bacterial artificial chromosome (BAC) probes specific to the
IgH or the MYC locus (Fig. 2D).
We similarly induced BCR/ABL1 translocation by Site1
targeting to the BCR locus of NCR1 cells and subsequent Site2
targeting to the ABL1 locus (Fig. 2E, Fig. S3 and Fig. S4). The
frequency of double-positive cells on day 7 of OHT stimulation
was (5.961.8)610
25 (n=10). To verify production of the BCR-
ABL1 translocation, several cell clones with a clean translocation
were obtained after transient expression of Flp recombinase in the
fluorescence-positive cells followed by flow-cytometric sorting and
limiting dilution for fluorescence-negative cells. Successful trans-
location in thus obtained cell clones was verified by FISH analysis
(not shown) and spectral karyotyping (SKY, a FISH-based
cytogenetic technique that allows the simultaneous identification
of all 24 human chromosomes with whole chromosome painting
probes labeled with different combination of fluorescent dyes)
(Fig. 2F). Production of BCR-ABL1 fusion protein was confirmed
by western blot analysis (Fig. 2G). Expected splicing between
juxtaposed exons was confirmed by sequencing reverse-transcrip-
tion PCR product (data not shown).
Induction of copy number variation
Recently, much attention has been paid to the copy-number
variation (CNV) in the human genome, which is considered to
have a greater impact on the phenotype than single nucleotide
polymorphism. Utilities of site-specific recombinases to generate
CNV were previously reported in several organisms including
yeast [15], plant [16], fly [17] and mouse [2]. To demonstrate the
feasibility of our system for generating CNV, we inserted Site1 and
Site2 into the same chromosome 14 (Fig. 3A) with an identical
orientation. For Site2 targeting, NSB1 cells were used, which were
used for recapitulation of MYC/IgH translocation (Fig. 2A–D) and
harbor Site1 at IGHA2 locus. Site 2 was targeted to an intergenic
region between LOC122631 and C14orf180, which lies 1.1-Mb
apart from Site1 to the centromere. Cre activation was expected to
result in two different outcomes. Recombination in the same DNA
molecule leads to deletion of the inter-loxP segment. This causes
GFP expression from fused Site1/2 (59 half of Site1 and 39 half of
Site2) in the chromosome and transient expression of DsRed from
Site2/1 (59 half of Site2 and 39 half of Site1) in the excised circular
product that eventually disappears. Alternatively, nonallelic
recombination at the G2/M phase of the cell cycle between sister
chromatids leads to inter-loxP duplication on one chromatid and
its deletion on the other (Fig. 3A). Subsequent cell division
generates both cells with duplication expressing only DsRed and
cells with deletion expressing only GFP. Therefore, irrespective of
the two recombination modes (intramolecular and intermolecular
recombination), GFP- and DsRed-positive cells represent cells
with deletion and duplication, respectively.
We analyzed double-targeted cells (NSK) selected after
Southern blotting (Fig. S5) and metaphase FISH using Site1 and
Site2 probes to examine whether Site2 integration occurred in the
Site1-integrated chromosome 14 (integration in cis) or in its
homologue (integration in trans) (Fig. 3B, Table 1). The four cis-
targeted clones were cultured in the presence of OHT. On day 7,
cells positive for either GFP or DsRed were observed
[(1.560.4)610
22; n=4] (Fig. 4A, top). Cells were passaged in
the absence of OHT for an additional 10 days, when the fraction
of double-positive cells significantly decreased from 0.4610
22 to
0.3610
23 (Fig. 4A, top; compare day 7 and day 17).
To confirm deletion or duplication, we sorted and cloned GFP-
and DsRed-positive populations. Among 12 GFP-only clones, 11
clones revealed similar GFP intensity (comparable to post 1, 2 in
Fig. 4A bottom), while 1 (post 3) showed higher GFP expression.
Profiles of the two DsRed-only clones (post 4, 5) were similar. PCR
analysis of genomic DNA of these clones using deletion- or
duplication-specific primers produced consistent results, except for
the post 3 clone (Fig. 4B), which retained the neomycin-resistant
gene that was detected by sequencing the PCR products.
Therefore, Cre-mediated excision of drug markers was efficient
but incomplete. Culture of DsRed-positive cells in the presence of
OHT generated GFP-positive cells, but not vice versa (Fig. 4A,
lower right). This observation is consistent with our interpretation
that DsRed expression represents cells with inter-loxP duplication.
Two clones determined to be mixed (NSK72 and NSK141) by
FISH analysis using Site1 and Site2 probes (Table 1) were
excluded from the following studies, because these clones may be a
mixture of cis- and trans-targeted clones. However, such a mixed
pattern can be explained by cross-hybridization between Site1 and
Site2, because identical sequence blocks occupy 29% and 38% of
Site1 and Site2 probes, respectively.
Application to assessment of proximity between gene
loci
In somatic cells of fly, homologue pairing (a phenomenon in
which paternal and maternal chromosomes spatially align) was
demonstrated by Flp-FRT-mediated chromosomal recombination
[18]. This observation suggests that recombination frequency can
be an indicator of proximity between two loci. Similar approach by
Cre-loxP system has been applied in the yeast chromosome [19].
Frequency of Cre-loxP-mediated long-range recombination was
shown to decrease with an increase in the inter-loxP distance in fly
[17] and in mouse embryonic stem cells [6]. To reproduce these
results in human cells, we inserted Site2 into Site1-pre-integrated
chromosome 14 at intervals of 1.1, 6.1, 10.5 and 39.8 Mb (Fig. 5A).
In this experiment, NSB1 cells with Site1 integration at IGHA2
Chromosomal Surgery by Cre
PLoS ONE | www.plosone.org 3 March 2010 | Volume 5 | Issue 3 | e9846Chromosomal Surgery by Cre
PLoS ONE | www.plosone.org 4 March 2010 | Volume 5 | Issue 3 | e9846(106.06 Mb on the chromosome 14 coordinate of the reference
human genome build 37.1) were used again. The Site2-targeted loci
are located at an intergenic region between LOC122631 and
C14orf180 (104.94 Mb) for 1.1-Mb interval; an intron of CCDC85C
(99.99 Mb) for 6.1-Mb interval; DICER1 (95.57 Mb) for 10.5-Mb
interval; and an intergenic region between FUT8 and NCOA4P
(66.30 Mb) for 39.8-Mb interval. For inversion to occur, Site2 was
oriented ina direction opposite to Site1.This is because celllethality
by deletions of large DNA segments might obscure the Cre
recombination frequency [6].
In case of the 1.1-Mb interval (NSC cells), six clones were
confirmed to be correctly targeted by Southern blotting (Fig. S6).
After 7 days of culture in the presence of OHT, these clones were
classified into two groups in terms of frequency of double-positive
cells: high group [(9.461.1)610
23; n=3] and low group
[(8.761.0)610
25; n=3]. FISH analysis using Site1 and Site2
probes revealed that high- and low-group clones were cis- and
trans-targeted, respectively (Fig. 5B, Table 2), which also allowed us
to classify the high and low groups as cis and trans groups,
respectively, for cells with other Site1–Site2 intervals. In case of
the 6.1-Mb interval (Fig. S7), the frequency of double-positive cells
after 7 days of OHT stimulation was significantly lower than that
seen with the 1.1-Mb interval: (1.260.6)610
23 (cis, n=4) and
(3.061.7)610
25 (trans, n=8). Likewise, the targeted clones of 10.5-
and 39.8-Mb intervals (Fig. S8 and Fig. S9) resulted in further
decreasing frequencies: (6.563.5)610
24 and (1.660.8)610
25 (cis,
n=4 and trans, n=3) for 10.5 Mb and (1.260.3)610
24 and
(8.965.9)610
26 (cis, n=4 and trans, n=7) for 39.8 Mb.
Plotting the frequencies of recombination versus different loxP
intervals indicated good linearity (Fig. 6A, 6B-i), suggesting that
the intrachromosomal recombination frequency is inversely
proportional to the distance between recombination sites. This
result is strikingly similar to a result in fly [17] and is consistent
with reported observation by Hi-C method and prediction by the
fractal globule model of chromatin organization [20]. However,
the linearity reduced with an increase in Cre expression provided
by a retroviral vector (Fig. 7) probably because multiple inversions
underestimate the real recombination frequency higher than 2%.
Cre expression in representative clones for each Site1-Site2
interval was augmented by infecting cells with Cre-expressing
retrovirus. Retroviral Cre protein but not that of MerCreMer was
detected using anti-Cre antibody (Fig. 7, upper panel), while
MerCreMer was detected in the presence of OHT by anti-
estrogen receptor a antibody. This result indicated that the
expression level of retroviral Cre was higher than that of
MerCreMer expressed from plasmid transgene.
Sister chromatid recombination in cis-targeted cells can also
lead to cell death associated with dicentric (two-centromere) and
acentric (no-centromere) chromosomes (Fig. 6B-ii), which might
be another reason for the reduced linearity under high Cre
activity. Unexpectedly, the trans group also exhibited a decreasing
trend according to increasing inter-loxP distance (Fig. 6A). In the
case of trans targeting, recombination results in formation of
dicentric and acentric chromosomes, leading to cell death (Fig. 6B-
iii). The decreasing trend of the trans group could be due to
accelerated cell death with longer intervals or homologue pairing
as previously observed in fly [18] and yeast [19]. Limited survival
of those cells was depicted by the disappearance of the double-
positive cells induced by OHT-treatment of trans-targeted NSC
cells after removal of OHT (Fig. 8A), indicating poor survival of
these cells presumably by formation of dicentric and acentric
chromosomes (Fig. 6B-iii). In contrast, the double positive cells
induced from the cis group of NSC cells (Fig. 8B) and those from
the NSK cells with loxP sites in the same orientation (Fig. 8C for
the trans group, Fig. 8D for the cis group) survived after removal of
OHT. This experiment indicates that our system can be applied to
studies of spatial organization of the mammalian genome based on
an easy and rapid flow-cytometric determination of recombination
frequencies.
In this study, we demonstrated the use of our novel system in
studying artificial chromosomal translocation, duplication, dele-
tion, and inversion as well as in determining gene proximity in a
human cell line. At the same time, this system may be useful for
screening of recessive mutations [5] and induction of specific
chromosomal loss [21] in cell lines or animal models. The
applications to cell lineage tracing and neural connection analysis
in animals may also be possible, taking advantage of infrequent
recombination between loxP sites introduced at identical locations
on homologous chromosomes [11]. The technical improvements
reported here will facilitate mammalian chromosome engineering
and better understanding of human diseases caused by chromo-
somal translocations and CNV.
Materials and Methods
Constructs
Procedures for construction of Site1 and Site2 targeting vectors
are described in Methods S1 including Fig. S10, Fig. S11 and
Table S1. pANMerCreMer-zeo was constructed by inserting a
blunt 1437-bp ClaI-BstPI fragment from pVgRXR (Invitrogen,
Carlsbad, CA), containing a zeocin-resistance gene in place of the
AatII-SacI neomycin-resistance gene segment of pANMerCre-
Mer-neo [14]. The Flp expression vector pCAGGS-FLPe was
purchased (Gene Bridges, Dresden, Germany). A retroviral vector
expression Cre, pCre-FBP, was constructed by inserting into pFB
vector (Stratagene, La Jolla, CA) a coding sequence of Cre amino-
Figure 2. Recapitulation of MYC/IgH and BCR/ABL1 translocations. A, Site1 vector (red triangle on chromosome 14) was targeted to the IGHA2
locus of Nalm-6 cells expressing tamoxifen-regulated Cre. Site2 vector (red triangle on chromosome 8) was subsequently targeted to the MYC locus
(red circle). The IgH enhancer is indicated by a green circle. B, Flow cytometric profiles of the indicated stages. Red circles indicate the sorted cell
populations. C, Confirmation of translocation by PCR. PCR products of expected sizes were observed for cells after translocation (post) but not for
cells before Cre expression (pre). H2O lanes show the no-template controls. Triangles above the transgene schemes represent primer positions (IgA2-
B41-F1 and MYC-B23-R1 for green, and MYC-B41-F1 and IgA2-B23-R1 for red), respectively. D, FISH analysis demonstrating MYC/IgH translocation for
cells after recombination by Flp, using BAC probes. Green probe hybridizes to a chromosome 14 region near Site1-integrated IgH locus on the
centromeric side. Red probe hybridizes to a chromosome 8 region near Site2-integrated MYC locus on the telomeric side. These probes co-localize
only after Cre-mediated translocation and appear as a yellow signal (right panel, box), magnification of which is shown in the inset. E, Site1 and Site2
vectors containing loxP sites (red rectangle) were targeted into the first intron of the BCR gene and the ABL1 gene, respectively. Vertical bars and
boxes connected with v-shaped lines indicate exon–intron structure of genes. The derivative chromosome 22 [der(22)] recapitulates the Philadelphia
(Ph) chromosome. F, SKY analysis of cells with artificial BCR/ABL1 translocation. The derivative chromosome 9 [der(9)] in the green box contains the
material (pink) translocated from chromosome 22. The amount of chromosome 9 material that was translocated to chromosome 22 was too small to
be resolved by this SKY analysis (Ph chromosome, pink box). The previously reported translocation between chromosomes 5 and 12 in Nalm-6 cells
[23] could be also detected. G, Western blot confirming expression of the BCR-ABL1 fusion protein (190 kD) after clean translocation (post) with
constitutive expression of ABL1 and GAPDH proteins.
doi:10.1371/journal.pone.0009846.g002
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with a DNA segment consisting of internal ribosome entry site and
puromycin-resistance gene.
Cell culture, transfection and gene targeting
Nalm-6 cells and derivatives were maintained in ES medium
(Nissui, Tokyo, Japan) supplemented with 10% fetal bovine serum,
Figure 3. Site1 and Site2 targeting for copy-number variation. A, Possible outcome of Cre-mediated recombination between two loxP sites
with an identical orientation in the same chromosome 14. Site1 was targeted to the IGHA2 locus within the IgH gene cluster. Site2 was targeted to a
region tentatively designated 104, 1.1 Mb centromeric to the IGHA2 loci. B, Results of representative two cis-targeted (NSK122 and NSK126) and two
trans-targeted clones (NSK107 and NSK108) are shown. The chromosomes 14 with Site1 and Site2 integration harbor red and green signals,
respectively, and are highlighted with boxes, magnifications of which are shown in insets.
doi:10.1371/journal.pone.0009846.g003
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micrograms of ScaI-linearized pANMerCreMer-zeo was electro-
porated into 2610
6 Nalm-6 cells using Nucleofector II (Amaxa,
Ko ¨ln, Germany) with Solution T and Program C-005. One of the
zeocin-resistant clones with OHT-dependent Cre activity assessed
by transient expression of the test substrate was designated as
NCR1 to be used in subsequent experiments. The Site1 and Site2
targeting vectors were linearized by one of the enzymes within the
multiple linearization sites and introduced into NCR1 and Site1-
targeted NCR1, respectively, using Nucleofector II. Drug-resistant
colonies were first screened by real-time SYBR-Green PCR with
Mx3000P (Stratagene) using genomic DNA isolated by FTA card
(Whatman, Kent, UK) as templates. The specific PCR products
were detected by a dissociation curve analysis, taking advantage of
the fact that the melting temperature of specific PCR products that
are $2 kb is significantly higher than that of non-specific products
including primer dimers. The polymerase was selected from
among PrimeSTAR HS, LA Taq HS (Takara, Otsu, Japan),
KOD FX (Toyobo, Osaka, Japan) and Phusion (Finnzyme, Espoo,
Finland) for the best efficiency and specificity upon amplification
using positive control CF and negative control Nalm-6 DNA.
Products with melting temperatures similar to CF were almost
always had the expected size upon 1% agarose-gel electrophoresis.
Positive clones were examined by Southern blotting using
upstream, internal and downstream probes labelled with the
AlkPhos Direct kit (GE Healthcare, Piscataway, NJ). Detection
was performed following 30 min of exposure to LAS-3000 mini
cool-CCD camera (Fuji, Tokyo, Japan). Transient expression of
pCAGGS-FLPe was obtained using Nucleofector II.
Fluorescence in situ hybridization
We performed two-color FISH analysis using two BAC clones
RP11-953L20 (located centromeric to the IgH gene; Spectrum-
Green-labeled) and RP11-55J15 (located telomeric to the MYC
gene; SpectrumOrange-labeled). Labeling reaction was done using
Nick Translation Kit (Abbott Molecular Inc., Des Plaines, IL) and
SpectrumGreen- and SpectrumOrange-labeled deoxyuridine tri-
phosphate (Abbott Molecular Inc.). For discrimination of cis and
trans targeting, we used PCR-amplified Site1 (3.8 kb) and Site2
(2.9 kb) probes labelled with SpectrumGreen and SpectrumOr-
ange, respectively. Images were taken with the fluorescence
microscope MD5000B (Leica, Wetzlar, Germany), equipped with
a cool charge-coupled device camera ORCA-ER (Hamamatsu
Photonics, Hamamatsu, Japan) and iVision-Mac software (BioVi-
sion Technologies, Exton, PA). For spectral karyotyping of BCR/
ABL1 translocation, hybridization was done using a SKYPaint kit
(Applied Spectral Imaging, Vista, CA) and detected by SD-200
(Applied Spectral Imaging).
Induction of recombination and flow cytometry
After double targeting, 100,000 Nalm-6 cells were inoculated in
1 ml of medium with or without 1 mM OHT (day 0). On day 3,
0.5 ml of cells was diluted to 5 ml while maintaining OHT
concentrations. Flow-cytometric analyses were performed by
FACSCalibur (Becton Dickinson, Franklin Lakes, NJ) on day 7
in most cases. In some cases, this was done on day 11 or later, in
which case the cells were diluted 10 times every 3 to 4 days. The
frequencies of fluorescence-positive cells were then calculated from
data acquired for one million cells using CellQuest software
(Becton Dickinson). When OHT-stimulated cells were to be
sorted, culture volume was doubled. Sorting was performed using
FACSCalibur.
Western blotting
We performed western blot analysis for the BCR-ABL1 fusion
protein using mouse monoclonal antibody against c-Abl [c-Abl(24-
11); Santa Cruz, Santa Cruz, CA] or GAPDH (6C1, Millipore,
Billerica, MA) and IR Dye800CW-labelled anti-mouse IgG (Li-
cor, Lincoln, NE) and detected the proteins using a Odyssey
scanner (Li-cor). Cre was detected using mouse monoclonal
antibody (7.23; Abcam, Cambridge, MA) and IRDye680CW-
labelled anti-mouse IgG (Li-cor). MerCreMer was detected with
rabbit polyclonal anti-human estrogen receptor a antibody (sc-
543, Santa Cruz) and IR Dye800CW-labelled anti-rabbit IgG (Li-
cor). Antibody incubation was 10 min at room temperature using
the SNAPi.d. Protein Detection System (Millipore).
Table 1. Targeting configuration of NSK cells with loxP sites spanning 1.1 Mb in the same direction.
Targeting configuration Clone No. of metaphase Colocalization Non-colocalization Frequency of fluorescence-positive cells
cis NSK122 8 7 1 1.2610
22
NSK126 7 7 0 1.3610
22
NSK164 7 7 0 1.6610
22
NSK171 8 7 1 2.0610
22
mean frequency (mean 6 standard deviation) 1.560.4610
22
trans NSK107 7 0 7 3.7610
24
NSK108 12 1 11 3.0610
24
NSK114 7 0 7 3.6610
24
NSK116 16 2 14 1.8610
24
NSK123 8 1 7 2.5610
24
NSK145 8 1 7 2.0610
24
mean frequency of (mean 6 standard deviation) 2.860.8610
24
mixed NSK72 7 3 4 3.8610
23
NSK141 14 6 8 2.3610
24
The numbers of metaphases analyzed and those which exhibited colocalization or non-colocalization of signals by Site1 and Site2 probes are shown with frequencies of
double-positive cells after 7 days of OHT stimulation.
doi:10.1371/journal.pone.0009846.t001
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Methods S1 Construction of Site1 and Site2 targeting vector.
Found at: doi:10.1371/journal.pone.0009846.s001 (0.03 MB
RTF)
Table S1 Oligonucleotide sequences. ‘‘P-’’ indicates 59 phos-
phorylation. PCR enzymes used to amplifiy DNA fragments are
shown. Blue letters indicate relevant ristriction sites. Green letters
indicate SV40 small-t intronic sequence. Red letters indicate att
site sequences.
Found at: doi:10.1371/journal.pone.0009846.s002 (0.04 MB
XLS)
Figure S1 Gene targeting strategy for IGHA2 locus and screening
summary. A, Structure of the IGHA2 loci encoding the constant
Figure 4. Induction of copy-number variation. A, Flow cytometric profiles of double-targeted cells, Cre-activated cells, and Cre-terminated cells
kept OHT-free for 10 days (top). Flow cytometric profiles of sorted cell clones and a DsRed-positive clone 10 days after Cre activation (bottom). B, PCR
confirmation of rearrangement for clones from cis- and trans-targeting cells. Clone numbers from 1 to 5 correspond to rearranged clone numbers (post)
in A. Clones 6 to 9 are derived from trans-targeted cells. Cells before Cre activation (pre), Nalm-6 and the no-template control (H2O) are included.
Triangles above the transgene schemes represent primer positions (IgA2-B41-F1 and 104-B41-R1 for green, and 104-B23-F1 and IgA2-B23-R1 for red).
doi:10.1371/journal.pone.0009846.g004
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band sizes on the Southern blot (table). Rectangles indicate exons
and the oval shape indicates the switch region of the IGHA2 locus
(Sa 2). Exon numbers are indicated in white. Regions of targeting
homology are indicated by parallel dotted lines with in-between
numbers depicting bp. Positions of DNA probes used for Southern
blotting are indicated by thick blue (upstream), black (internal) and
red (downstream) lines. Numbers with bp above bidirectional
arrows represent the distance between relevant restriction sites.
Primer positions for PCR screening are indicated by arrowheads.
Unidirectional arrows indicate direction toward the centromere or
the telomere. The table lists the expected sizes of bands on the
Southern blotting using the indicated enzymes and probes. Due to
high homology between the IGHA2 and the IGHA1 loci encoding
Figure 5. Site1 and Site2 integration for assessment of proximity between loci. A, Scheme of chromosome 14 after cis targeting with the
indicated Site1–Site2 intervals. B, FISH analyses of representative two cis-targeted (NSC27 and NSC71) and two trans-targeted clones (NSC94 and
NSC169) are shown. The chromosomes 14 with Site1 and Site2 integration harbor green and red signals, respectively, and are highlighted with boxes,
magnifications of which are shown in insets.
doi:10.1371/journal.pone.0009846.g005
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PLoS ONE | www.plosone.org 9 March 2010 | Volume 5 | Issue 3 | e9846Table 2. Targeting configuration of NSC cells with loxP sites spanning 1.1 Mb in the opposite direction.
Targeting configuration Clone No. of metaphase Colocalization Non-colocalization Frequency of fluorescence-positive cells
cis NSC27 8 8 0 1.0610
22
NSC71 8 8 0 8.2610
23
NSC130 8 7 1 9.6610
23
mean frequency (mean 6 standard deviation) 9.360.9610
23
trans NSC94 16 1 15 8.8610
25
NSC169 8 0 8 7.7610
25
mean frequency (mean) 8.3610
25
The numbers of metaphases analyzed and those which exhibited colocalization or non-colocalization of signals by Site1 and Site2 probes are shown with frequencies of
double-positive cells after 7 days of OHT stimulation.
doi:10.1371/journal.pone.0009846.t002
Figure 6. Relationship between recombination frequency and genetic distance. A, Plots of physical distance in the chromosome on the x
axis and frequency of recombination on the y axis for cis- and trans-targeted cells. B, Outcome of inter-loxP recombination in cis- and trans-targeted
cells.
doi:10.1371/journal.pone.0009846.g006
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PLoS ONE | www.plosone.org 10 March 2010 | Volume 5 | Issue 3 | e9846IgA1, expected signals from both loci are shown for wild-type (WT)
and targeted (knockout, KO) alleles. B, Southern blot using the
indicated enzymes and probes for representative five clones (#138,
#148, #159, #201 and #209). Genomic DNA of these clones and
their subclones (1–3) with parental NCR1 cells were analyzed.
Outermost lanes of each panel were loaded with a size marker. The
expected positions of WT and KO alleles are shown by arrowheads.
The PvuII fragments detected by the upstream probe from the
Figure 7. Effect of augmented Cre activity on inversion frequency. A, Representative clones for each loxP interval (NSC27 for 1.1 Mb, NSF331
for 6.1 Mb, NSG118 for 10.5 Mb, and NSI95 for 39.8 Mb) were infected with a retrovirus expressing nuclear localization signal (NLS)-tagged Cre and
puromycin-resistance gene. Simultaneously, tamoxifen (OHT) was added to activate MerCreMer. One day after infection, 0.25 mg/ml puromycin was
added to select infected cells. Retrovirally Cre-transduced cells (open diamond) were analyzed by flow cytometry on day 11 to measure the frequency
of fluorescence-positive cells. As a control, non-infected cells (red circle) were stimulated with OHT. B, Western blotting for retrovirally transduced Cre
and MerCreMer proteins in NSC27 and NSMyc23 cells, the latter of which is clone #23 used for MYC/IgH translocation induction (Fig. 2B–D and Fig.
S2). Retrovirus-infected cells were maintained in the presence of puromycin more than two weeks before lysate preparation.
doi:10.1371/journal.pone.0009846.g007
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designated a and b alleles. The longer a allele appeared to lose an
upstream PvuII site in the allele b fragment. C, Summary of clone
numbers is indicated. Subclone 1 of clone #159 was designated
NSB1, which was subsequently targeted in all experiments except
induction of BCR/ABL1 translocation.
Found at: doi:10.1371/journal.pone.0009846.s003 (1.83 MB TIF)
Figure S2 Gene targeting strategy for MYC locus and screening
summary. A, Structure of the MYC loci before and after targeting
(upper panel) and expected band sizes on the Southern blot (table).
Rectangles indicate exons of the MYC gene. Exon numbers are
indicated in white. Regions of targeting homology are indicated by
parallel dotted lines with in-between numbers depicting bp.
Positions of DNA probes used for Southern blotting are indicated
by thick blue (upstream), black (internal) and red (downstream)
lines. Numbers with bp above bidirectional arrows represent the
distance between relevant restriction sites. Primer positions for
PCR screening are indicated by arrowheads. Unidirectional
arrows indicate direction toward the centromere or the telomere.
The table lists the expected sizes of bands on the Southern blot
obtained using the indicated enzymes and probes for wild-type
(WT) and targeted (knockout, KO) alleles. B, Southern blot using
the indicated enzymes and probes for eight clones and parental
Figure 8. Time course of fluorescence-positive cells in Cre-activated NSC and NSK cells. Seven days after NSC and NSK cells were
stimulated with OHT to activate MerCreMer, the culture was split into two: one with continued Cre activation (square) and the other without OHT to
terminate Cre activation (triangle). Frequencies of fluorescence-positive cells at the indicated time points were measured by flow cytometry and
plotted for NSC (inverted loxP sites with a 1.1-Mb interval) trans-targeted cells (A) and cis-targeted cells (B), and NSK (direct loxP sites with a 1.1-Mb
interval) trans-targeted cells (C) and cis-targeted cells (D).
doi:10.1371/journal.pone.0009846.g008
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size marker. Expected positions of WT and KO alleles are shown
by arrowheads. C, Summary of clone numbers is indicated.
Found at: doi:10.1371/journal.pone.0009846.s004 (2.78 MB TIF)
Figure S3 Gene targeting strategy for BCR locus and screening
summary. A, Structure of the BCR loci before and after targeting
(upper panel) and expected band sizes on the Southern blot (table).
Rectangles indicate exons of the BCR gene. Exon numbers are
indicated in white. Regions of targeting homology are indicated by
parallel dotted lines with in-between numbers depicting bp.
Positions of DNA probes used for Southern blotting are indicated
by thick blue (upstream), black (internal) and red (downstream)
lines. Numbers with bp above bidirectional arrows represent the
distance between relevant restriction sites. Primer positions for
PCR screening are indicated by arrowheads. Unidirectional
arrows indicate direction toward the centromere or the telomere.
The table lists the expected sizes of bands on the Southern blot
using the indicated enzymes and probes for wild-type (WT) and
targeted (knockout, KO) alleles. B, Southern blot using the
indicated enzymes and probes for 14 clones and parental NCR1
cells. Outermost lanes of each panel were loaded with the size
marker. Expected positions of WT and KO alleles are shown by
arrowheads. Clone #177 (NSE177) was subsequently targeted
with an ABL1-targeting vector. C, Summary of clone numbers is
indicated.
Found at: doi:10.1371/journal.pone.0009846.s005 (1.20 MB TIF)
Figure S4 Gene targeting strategy for ABL1 locus and screening
summary. A, Structure of the ABL1 loci before and after targeting
(upper panel) and expected band sizes on the Southern blot (table).
Rectangles indicate exons of the ABL1 gene. Exon numbers are
indicated in white. Regions of targeting homology are indicated by
parallel dotted lines with in-between numbers depicting bp.
Positions of DNA probes used for Southern blotting are indicated
by thick blue (upstream), black (internal) and red (downstream)
lines. Numbers with bp above bidirectional arrows represent the
distance between relevant restriction sites. Primer positions for
PCR screening are indicated by arrowheads. Unidirectional
arrows indicate direction toward the centromere or the telomere.
The table lists the expected sizes of bands on the Southern blot
using the indicated enzymes and probes for wild-type (WT) and
targeted (knockout, KO) alleles. B, Southern blot using the
indicated enzymes and probes for 10 clones and parental NSE177
cells. Outermost lanes of each panel were loaded with the size
marker. Expected positions of WT and KO alleles are shown by
arrowheads. C, Summary of clone numbers is indicated.
Found at: doi:10.1371/journal.pone.0009846.s006 (2.81 MB TIF)
Figure S5 Gene targeting strategy for 104 locus for deletion/
duplication and screening summary. A, EcoRI restriction map of a
region at 104 Mb on the coordinate of chromosome 14, 1.1 Mb
centromeric to the IGHA2 loci (upper panel), and expected band
sizes on the Southern blot (table). Regions of targeting homology
are indicated by parallel dotted lines with in-between numbers
depicting bp. Positions of DNA probes used for Southern blotting
are indicated by thick blue (upstream), black (internal) and red
(downstream) lines. Numbers with bp above bidirectional arrows
represent the distance between relevant restriction sites. Primer
positions for PCR screening are indicated by arrowheads.
Unidirectional arrows indicate direction toward the centromere
or the telomere. The table lists expected sizes of bands on the
Southern blot using the indicated enzymes and probes for wild-
type (WT) and targeted (knockout, KO) alleles. B, Southern blot
using the indicated enzymes and probes for 14 (NSK) clones and
parental NSB1 cells. Outermost lanes of each panel were loaded
with the size marker. Expected positions of WT and KO alleles are
shown by arrowheads. Two extra bands on the upstream probe
blot indicated by open arrowheads and asterisks appeared to be
derived from a highly homologous sequence on chromosome 13.
C, Summary of clone numbers is indicated.
Found at: doi:10.1371/journal.pone.0009846.s007 (1.94 MB TIF)
Figure S6 Gene targeting strategy for 104 locus for inversion
and screening summary. A, EcoRI restriction map of a region at
104 Mb on the coordinate of chromosome 14, 1.1 Mb centro-
meric to the IGHA2 loci (upper panel), and expected band sizes on
the Southern blot (table). Regions of targeting homology are
indicated by parallel dotted lines with in-between numbers
depicting bp. Positions of DNA probes used for Southern blotting
are indicated by thick blue (upstream) and red (downstream) lines.
Numbers with bp above bidirectional arrows represent the
distance between relevant restriction sites. Primer positions for
PCR screening are indicated by arrowheads. Unidirectional
arrows indicate direction toward the centromere or the telomere.
The table lists the expected sizes of bands on the Southern blotting
using the indicated enzymes and probes for wild-type (WT) and
targeted (knockout, KO) alleles. B, Southern blot using the
indicated enzymes and probes for 11 (NSC) clones and parental
NSB1 cells. Outermost lanes of each panel were loaded with the
size marker. Expected positions of WT and KO alleles are shown
by arrowheads. C, Summary of clone numbers is indicated.
Found at: doi:10.1371/journal.pone.0009846.s008 (1.86 MB TIF)
Figure S7 Gene targeting strategy for 99 locus for inversion and
screening summary. A, EcoRI restriction map of a region at
99 Mb on the coordinate of chromosome 14, 6.1 Mb centromeric
to the IGHA2 loci (upper panel), and expected band sizes on the
Southern blotting (table). Regions of targeting homology are
indicated by parallel dotted lines with in-between numbers
depicting bp. Positions of DNA probes used for Southern blotting
are indicated by thick blue (upstream), black (internal) and red
(downstream) lines. Numbers with bp above bidirectional arrows
represent the distance between relevant restriction sites. Primer
positions for PCR screening are indicated by arrowheads.
Unidirectional arrows indicate direction toward the centromere
or the telomere. The table lists the expected sizes of bands on the
Southern blot using the indicated enzymes and probes for wild-
type (WT) and targeted (knockout, KO) alleles. B, Southern blot
using the indicated enzymes and probes for 13 (NSF) clones and
parental NSB1 cells. Outermost lanes of each panel were loaded
with the size marker. Expected positions of WT and KO alleles are
shown by arrowheads. C, Summary of clone numbers is indicated.
Found at: doi:10.1371/journal.pone.0009846.s009 (1.95 MB TIF)
Figure S8 Gene targeting strategy for 95 locus for inversion and
screening summary. A, Restriction map of the DICER1 locus at
95 Mb on the coordinate of chromosome 14, 10.5 Mb centro-
meric to the IGHA2 loci (upper panel), and expected band sizes on
the Southern blot (table). Rectangles indicate exons of the DICER1
gene. Some of exon numbers are indicated in white. Regions of
targeting homology are indicated by parallel dotted lines with in-
between numbers depicting bp. Positions of DNA probes used for
Southern blotting are indicated by thick blue (upstream), black
(internal) and red (downstream) lines. Numbers with bp above
bidirectional arrows represent the distance between relevant
restriction sites. Primer positions for PCR screening are indicated
by arrowheads. Unidirectional arrows indicate direction toward
the centromere or the telomere. The table lists expected sizes of
bands on the Southern blot using the indicated enzymes and
probes for wild-type (WT) and targeted (knockout, KO) alleles. B,
Southern blot using the indicated enzymes and probes for 16
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panel were loaded with the size marker. Expected positions of WT
and KO alleles are shown by arrowheads. C, Summary of clone
numbers is indicated.
Found at: doi:10.1371/journal.pone.0009846.s010 (2.94 MB TIF)
Figure S9 Gene targeting strategy for 65 locus for inversion and
screening summary. A, Restriction map of a region at 65 Mb on
the coordinate of chromosome 14, 39.8 Mb centromeric to the
IGHA2 loci (upper panel), and expected band sizes on the
Southern blot (table). Regions of targeting homology are indicated
by parallel dotted lines with in-between numbers depicting bp.
Positions of DNA probes used for Southern blotting are indicated
by thick blue (upstream), black (internal) and red (downstream)
lines. Numbers with bp above bidirectional arrows represent the
distance between relevant restriction sites. Primer positions for
PCR screening are indicated by arrowheads. Unidirectional
arrows indicate direction toward the centromere or the telomere.
The table lists the expected sizes of bands on the Southern blot
using the indicated enzymes and probes for wild-type (WT) and
targeted (knockout, KO) alleles. B, Southern blot using the
indicated enzymes and probes for 13 (NSI) clones and parental
NSB1 cells. Outermost lanes of each panel were loaded with the
size marker. Expected positions of WT and KO alleles are shown
by arrowheads. C, Summary of clone numbers is indicated.
Found at: doi:10.1371/journal.pone.0009846.s011 (3.14 MB TIF)
Figure S10 Construction scheme part 1. For details, see
Methods S1.
Found at: doi:10.1371/journal.pone.0009846.s012 (0.61 MB TIF)
Figure S11 Construction scheme part 2. For details, see
Methods S1.
Found at: doi:10.1371/journal.pone.0009846.s013 (1.74 MB TIF)
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